Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis

Abstract Objective We aimed to provide a reference based on evidence for an individualized clinical medication of high-dose methotrexate (HD-MTX) in osteosarcoma patients by evaluating the effect of gene polymorphism on adverse reactions of HD-MTX usage. Methods Several databases were combed for res...

Full description

Bibliographic Details
Main Authors: Ben Liu, Gang Liu, Binbin Liu, Yao Guo, Ningning Peng, Tiejun Li
Format: Article
Language:English
Published: BMC 2024-01-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-023-03287-0
_version_ 1797355704672059392
author Ben Liu
Gang Liu
Binbin Liu
Yao Guo
Ningning Peng
Tiejun Li
author_facet Ben Liu
Gang Liu
Binbin Liu
Yao Guo
Ningning Peng
Tiejun Li
author_sort Ben Liu
collection DOAJ
description Abstract Objective We aimed to provide a reference based on evidence for an individualized clinical medication of high-dose methotrexate (HD-MTX) in osteosarcoma patients by evaluating the effect of gene polymorphism on adverse reactions of HD-MTX usage. Methods Several databases were combed for research on the association between gene polymorphisms and adverse reactions to HD-MTX up to January 2023. A meta-analysis and/or descriptive analysis on the incidence of HD-MTX-related adverse reactions were conducted by using clinical studies meeting inclusion criteria. Results Twelve studies involving 889 patients were included. There were 8, 6, 5, and 4 studies related to MTHFR C677T, MTHFR A1298C, RFC1 G80A, and MDR1 C3435T polymorphisms, respectively. The results of the meta-analysis showed that the MTHFR C677T polymorphism was associated with G3-4 hepatotoxicity, G3-4 nephrotoxicity, G3-4 gastrointestinal toxicity, and G3-4 mucositis under the recessive genetic model (MM vs. Mm/mm). Limited research showed that MTHFR C677T was associated with G3-4 nephrotoxicity in the allelic genetic model (M vs. m). MTHFR A1298C polymorphism was associated with a decreased risk of adverse reactions to HD-MTX usage, without statistical significance. This review's descriptive analysis showed no significant correlation between the RFC1 G80A, and MDR1 C3435T polymorphism and adverse reactions of HD-MTX. Conclusion The MTHFR C677T mutation may enhance the risk of HD-MTX adverse reactions in osteosarcoma patients. Existing studies have not found a significant correlation between the MTHFR A1298C, RFC1 G80A, and MDR1 C3435T polymorphism and adverse reactions caused by HD-MTX. Lastly, this conclusion was limited because of few studies.
first_indexed 2024-03-08T14:14:56Z
format Article
id doaj.art-37beea97d6b446338e49331a7749ed1b
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-03-08T14:14:56Z
publishDate 2024-01-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-37beea97d6b446338e49331a7749ed1b2024-01-14T12:25:27ZengBMCWorld Journal of Surgical Oncology1477-78192024-01-0122111010.1186/s12957-023-03287-0Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysisBen Liu0Gang Liu1Binbin Liu2Yao Guo3Ningning Peng4Tiejun Li5Fourth Department of Orthopedics, Cangzhou Central HospitalFourth Department of Orthopedics, Cangzhou Central HospitalFourth Department of Orthopedics, Cangzhou Central HospitalCentral Laboratory, Cangzhou Central HospitalFourth Department of Orthopedics, Cangzhou Central HospitalLegal Affairs Office, Cangzhou Central HospitalAbstract Objective We aimed to provide a reference based on evidence for an individualized clinical medication of high-dose methotrexate (HD-MTX) in osteosarcoma patients by evaluating the effect of gene polymorphism on adverse reactions of HD-MTX usage. Methods Several databases were combed for research on the association between gene polymorphisms and adverse reactions to HD-MTX up to January 2023. A meta-analysis and/or descriptive analysis on the incidence of HD-MTX-related adverse reactions were conducted by using clinical studies meeting inclusion criteria. Results Twelve studies involving 889 patients were included. There were 8, 6, 5, and 4 studies related to MTHFR C677T, MTHFR A1298C, RFC1 G80A, and MDR1 C3435T polymorphisms, respectively. The results of the meta-analysis showed that the MTHFR C677T polymorphism was associated with G3-4 hepatotoxicity, G3-4 nephrotoxicity, G3-4 gastrointestinal toxicity, and G3-4 mucositis under the recessive genetic model (MM vs. Mm/mm). Limited research showed that MTHFR C677T was associated with G3-4 nephrotoxicity in the allelic genetic model (M vs. m). MTHFR A1298C polymorphism was associated with a decreased risk of adverse reactions to HD-MTX usage, without statistical significance. This review's descriptive analysis showed no significant correlation between the RFC1 G80A, and MDR1 C3435T polymorphism and adverse reactions of HD-MTX. Conclusion The MTHFR C677T mutation may enhance the risk of HD-MTX adverse reactions in osteosarcoma patients. Existing studies have not found a significant correlation between the MTHFR A1298C, RFC1 G80A, and MDR1 C3435T polymorphism and adverse reactions caused by HD-MTX. Lastly, this conclusion was limited because of few studies.https://doi.org/10.1186/s12957-023-03287-0High-dose MethotrexateAdverse ReactionsOsteosarcomaGene PolymorphismMeta-analysis
spellingShingle Ben Liu
Gang Liu
Binbin Liu
Yao Guo
Ningning Peng
Tiejun Li
Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis
World Journal of Surgical Oncology
High-dose Methotrexate
Adverse Reactions
Osteosarcoma
Gene Polymorphism
Meta-analysis
title Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis
title_full Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis
title_fullStr Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis
title_full_unstemmed Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis
title_short Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis
title_sort correlation between gene polymorphism and adverse reactions of high dose methotrexate in osteosarcoma patients a systematic review and meta analysis
topic High-dose Methotrexate
Adverse Reactions
Osteosarcoma
Gene Polymorphism
Meta-analysis
url https://doi.org/10.1186/s12957-023-03287-0
work_keys_str_mv AT benliu correlationbetweengenepolymorphismandadversereactionsofhighdosemethotrexateinosteosarcomapatientsasystematicreviewandmetaanalysis
AT gangliu correlationbetweengenepolymorphismandadversereactionsofhighdosemethotrexateinosteosarcomapatientsasystematicreviewandmetaanalysis
AT binbinliu correlationbetweengenepolymorphismandadversereactionsofhighdosemethotrexateinosteosarcomapatientsasystematicreviewandmetaanalysis
AT yaoguo correlationbetweengenepolymorphismandadversereactionsofhighdosemethotrexateinosteosarcomapatientsasystematicreviewandmetaanalysis
AT ningningpeng correlationbetweengenepolymorphismandadversereactionsofhighdosemethotrexateinosteosarcomapatientsasystematicreviewandmetaanalysis
AT tiejunli correlationbetweengenepolymorphismandadversereactionsofhighdosemethotrexateinosteosarcomapatientsasystematicreviewandmetaanalysis